Thomvest gives Prometic access to $100 mln line of credit
Laval, Québec-based biopharmaceutical company Prometic Life Sciences Inc (TSX: PLI) has secured a $100 million (US$80 million) line of credit from an affiliate of Thomvest Asset Management, the investment vehicle of Canadian billionaire Peter Thomson. The company, which specializes in bioseparation and the development of plasma-derived and small-molecule therapeutics, said the facility's proceeds will support it prior to the expected flow of revenues from sales of plasminogen and other monetization events. Led by President and CEO Pierre Laurin, ProMetic earlier this year raised funding from both Thomvest and California Capital Equity.
23 October 2017•4 mins read
